SFX by Ex Libris Inc.

Title:	Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry
Source:	Science [0036-8075] Jae, L T yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Carette, Jan E. "Ebola virus entry requires the cholesterol transporter Niemann-Pick C1." Nature 477.7364 (2011): 340-343.
description	2.	Vuillaumier Barrot, S. "Identification of Mutations in TMEM5 and ISPD as a Cause of Severe Cobblestone Lissencephaly." American journal of human genetics 91.6 (2012): 1135-1143.
description	3.	Giasson, Benoit I I. "Initiation and synergistic fibrillization of tau and alpha-synuclein." Science 300.5619 (2003): 636-640.
description	4.	Imperiali, M. "Post-translational modification of alpha-dystroglycan is not critical for lymphocytic choriomeningitis virus receptor function in vivo." The Journal of general virology 89.11 (2008): 2713-2722.
description	5.	Stanford, W L L. "Gene-trap mutagenesis: past, present and beyond." Nature reviews. Genetics 2.10 (2001): 756-68.
description	6.	CÃÂtÃÂ, M. "Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection." Nature 477.7364 (2011): 344-348.
description	7.	Waxman, Elisa A. "Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau." The Journal of neuroscience 31.21 (2011): 7604-7618.
description	8.	Carette, Jan E. "Haploid Genetic Screens in Human Cells Identify Host Factors Used by Pathogens." Science 326.5957 (2009): 1231-5.
description	9.	Zampieri, CA A. "Immunopathology of highly virulent pathogens: insights from Ebola virus." Nature immunology 8.11 (2007): 1159-1164.
description	10.	Feldmann, H. "Ebola haemorrhagic fever." Lancet 377.9768 (2010): 849-862.
description	11.	Chandran, K. "Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection." Science 308.5728 (2005): 1643-5.
description	12.	Galpern, W. "Interface between tauopathies and synucleinopathies: A tale of two proteins." Annals of neurology 59.3 (2006): 449-58.
description	13.	Luk, Charlotte M. "α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration." Cell Reports 7.6 (2014): 2054-2065.
description	14.	Karagiannis, N. ""The Greek Financial Crisis and a Developmental Path to Recovery: Lessons and Options."." International journal of business and social science 3.13 (2012): 22-37.
description	15.	Campbell, Kevin P. "Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy." The Journal of clinical investigation 122.9 (2012): 3330-42.
description	16.	Campbell, T. "ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome." Nature Genetics 44.5 (2012): 575-80.
description	17.	Thammongkol, S. "Efficacy of the ketogenic diet: Which epilepsies respond?" Epilepsia 53.3 (2012): -9.
description	18.	Puente, Xose S. "Exome Sequencing and Functional Analysis Identifies BANF1 Mutation as the Cause of a Hereditary Progeroid Syndrome." American journal of human genetics 88.5 (2011): 650-656.
description	19.	Kamp, F. "Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1." The EMBO Journal 29.20 (2010): 3571-3589.
description	20.	Trojanowski, J. "More than just two peas in a pod: Common amyloidogenic properties of tau and < alpha >-synuclein in neurodegenerative diseases." Trends in neurosciences 27.3 (2004): 129-134.